Next Article in Journal
Synthesis of Quinoxaline 1,4-di-N-Oxide Analogues and Crystal Structure of 2-Carbomethoxy-3-hydroxyquinoxaline-di-N-oxide
Previous Article in Journal
Cardanol-Based Materials as Natural Precursors for Olefin Metathesis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

High Functionalization of 5-Nitro-1H-imidazole Derivatives: The TDAE Approach

Laboratoire de Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Universités d’Aix-Marseille I, II et III – CNRS, UMR 6264: Laboratoire Chimie Provence, 27 Bd Jean Moulin, 13385 Marseille Cedex 05, France
*
Author to whom correspondence should be addressed.
Molecules 2011, 16(8), 6883-6893; https://doi.org/10.3390/molecules16086883
Submission received: 20 July 2011 / Revised: 5 August 2011 / Accepted: 8 August 2011 / Published: 12 August 2011

Abstract

:
We report herein the synthesis of substituted 2--[4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]-1-arylethanols, ethyl 3-[4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)-phenyl]-2-hydroxypropanoate and 2-[4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)benzyl]-2-hydroxy-acenaphthylen-1(2H)-one from the reactions of 4-[4-(chloromethyl)phenyl]-1,2-dimethyl-5-nitro-1H-imidazole with various aromatic carbonyl and α-carbonyl ester derivatives using tetrakis(dimethylamino)ethylene (TDAE) methodology.

Graphical Abstract

1. Introduction

The 5-nitroimidazole scaffold is well-known for displaying major anti-infectious activities [1,2,3,4,5,6]. Several 5-nitroimidazole-containing active principles such as metronidazole, secnidazole and ornidazole are commonly used in medecine. These chemotherapeutic agents inhibit the growth of both anaerobic bacteria and some anaerobic protozoa [7]. Nowadays, the most clinically used drug-compounds for the treatment of both infections caused by protozoa such as Trichomonas vaginalis, Entamœba histolytica, Giardia intestinalis and infections induced by anaerobic bacteria is metronidazole. However, the 5-nitroimidazoles have been found to possess a high mutagenic activity in prokaryotic micro-organisms. A nitroimidazole possessing good pharmacological activities with no mutagenicity [8] would be of great interest, not only from a safety point of view, but would also provide a basis for further investigations on the mechanism(s) involved in their mutagenicity. Moreover, emergence of metronidazole-resistant Trichomonas vaginalis has resulted in decreased success of current therapies [9,10]. These refractory cases are usually treated with higher doses of metronidazole, which leads in turn to an increase in the occurrence of side effects [10,11], so alternative curative therapies are needed.
In continuation of our program directed towards the study of electron transfer reactions in heterocyclic series [12,13,14], we recently investigated SRN1 (unimolecular radical nucleophilic substitution) reactions of 4(5)-[4-(chloromethyl)phenyl]-1,2-dimethyl-5(4)-nitro-1H-imidazoles, involving long distance (six bonds) between the electron-withdrawing and leaving groups (LD-SRN1). The nitronate anions reacted by the substitution at the chloromethyl group and the reaction was very probably mediated by a SRN1 mechanism [15].
Tetrakis(dimethylamino)ethylene (TDAE) is a reducing agent which reacts with halogenated derivatives to generate an anion under mild conditions via two sequential transfers of one electron [16,17,18]. We have shown that from o- or p-nitrobenzyl chloride, TDAE could generate a nitrobenzyl carbanion which is able to react with various electrophiles [19]. Since 2003, and using this strategy, we have developed several reactions between nitrobenzylic, heterocyclic or quinonic substrates and a series of carbonylated electrophiles such as aldehydes [19,20,21,22], ketones [19,20,21,22], α-ketoesters [23,24,25], α-ketolactams [26], α-diketones [27,28] and diethyl ketomalonate [23,24,25] leading to the corresponding alcohol adducts. In continuation of our program directed toward the study of electron transfer reactions of bioreductive alkylating agents and the preparation of new and potentially safer nitroimidazoles, we report herein the synthesis of some highly functionalized 5-nitro-1H-imidazoles from the reaction of 4-[4-(chloromethyl)phenyl]-1,2-dimethyl-5-nitro-1H-imidazole with various aromatic carbonyl and α-carbonyl ester derivatives using TDAE methodology.

2. Results and Discussion

4-[4-(Chloromethyl)phenyl]-1,2-dimethyl-5-nitro-1H-imidazole (1) was prepared from the previously described [4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]methanol [29], according to a classical chlorination reaction with SOCl2 [20] (Scheme 1).
Scheme 1. Preparation of 4-[4-(chloromethyl)phenyl]-1,2-dimethyl-5-nitro-1H-imidazole (1).
Scheme 1. Preparation of 4-[4-(chloromethyl)phenyl]-1,2-dimethyl-5-nitro-1H-imidazole (1).
Molecules 16 06883 g001
The reaction of 1 with 3 equivalents of various aromatic aldehydes 2a-j in the presence of TDAE at –20 °C for 1 h, followed by 24 h at rt (Scheme 2), led to the corresponding alcohol derivatives 3a-j in moderate to good yields (24–78%) as shown in Table 1.
Scheme 2. Reaction of 1 with various carbonyl compounds using TDAE strategy.
Scheme 2. Reaction of 1 with various carbonyl compounds using TDAE strategy.
Molecules 16 06883 g002
Table 1. Products’ yields from the reaction of 1 with various carbonyl compounds using TDAE strategy.
Table 1. Products’ yields from the reaction of 1 with various carbonyl compounds using TDAE strategy.
Carbonyl compoundProduct aProduct numberYield (%) b
2a Molecules 16 06883 i001 Molecules 16 06883 i0023a69
2b Molecules 16 06883 i003 Molecules 16 06883 i0043b46
2c Molecules 16 06883 i005 Molecules 16 06883 i0063c37
2d Molecules 16 06883 i007 Molecules 16 06883 i0083d24
2e Molecules 16 06883 i009 Molecules 16 06883 i0103e60
2f Molecules 16 06883 i011 Molecules 16 06883 i0123f68
2g Molecules 16 06883 i013 Molecules 16 06883 i0143g78
2h Molecules 16 06883 i015 Molecules 16 06883 i0163h30
2i Molecules 16 06883 i017 Molecules 16 06883 i0183i45
2j Molecules 16 06883 i019 Molecules 16 06883 i0203j25
2k Molecules 16 06883 i021 Molecules 16 06883 i0223k42
2l Molecules 16 06883 i023 Molecules 16 06883 i0243l45
2mc Molecules 16 06883 i025 Molecules 16 06883 i0263m64
a All the reactions are performed using 3 equivalents of carbonyl compounds 2a-l, 1 equivalent of chloride 1 and 1 equivalent of TDAE in anhydrous DMF stirred at –20 °C for 1 h and then warmed up to rt for 24 h. b % Yield relative to chloride 1. c The reaction is performed using 3 equivalents of carbonyl compounds 2m, 1 equivalent of chloride 1 and 1 equivalent of TDAE in anhydrous DMF stirred at –20 °C for 1 h and then warmed up to 80 °C for 24 h.
High yields were obtained with p-nitrobenzaldehyde (2a), o-bromobenzaldehyde (2f) and p-cyanobenzaldehyde (2g), whereas p-chlorobenzaldehyde (2d), p-methylbenzaldehyde (2j) and 6-nitroveratraldehyde (2h) produced low yields. In summary, the difference of yields seems explained by the electronic effects, whereby the electron-withdrawing groups furnished the best yields, the electron-donating groups furnished the lowest yields and the halogen groups led to varied yields. The different yields with halobenzaldehydes could be explained by some purification problems encountered with the compound 3d. With nitrobenzaldehydes, steric hindrance could explain the difference between the o- and m-nitrobenzaldehyde (37% versus 46%). Moreover, after the reaction with aromatic aldehydes, we have investigated the reaction of 1 with α-keto-ester derivatives such as ethyl glyoxylate (2k), with an α-diketone such as acenaphthenedione (2l) and with a ketone like p-nitroacetophenone (2m). The reaction of 1 in the presence of TDAE with these electrophiles furnished the corresponding hydroxyl derivatives 3k-m in moderate to good yields (42–64%), as shown in Table 1. As observed in the p-nitrobenzyl series [19], due to its poor reactivity, p-nitroacetophenone (2l) needed heating for 24 h at 80 °C to drive the reaction to completion.

3. Experimental

Melting points were determined on Büchi B-540 and are uncorrected. Elemental analyses were carried out at the Spectropole, Faculté des Sciences et Techniques de Saint-Jérome. Both 1H- and 13C-NMR spectra were determined on Bruker ARX 200 spectrometer. The 1H chemical shifts were reported as parts per million downfield from tetramethylsilane (Me4Si), and the 13C chemical shifts were referenced to the solvent peak of CDCl3 (76.9 ppm). The following adsorbent was used for column chromatography: silica gel 60 (Merck, 230–400 mesh). Thin-layer chromatography was performed with silica gel Merck 60F-254 (0.25 mm layer thickness).
4-[4-(Chloromethyl)phenyl]-1,2-dimethyl-5-nitro-1H-imidazole (1): This compound was prepared from [4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]methanol [29], according to a classical chlorination reaction with SOCl2 [20]. Yellow solid; mp 120 °C (isopropyl alcohol); 1H-NMR (CDCl3) δ: 2.51 (s, 3H, CH3), 3.90 (s, 3H, CH3), 4.62 (s, 2H, CH2), 7.45 (d, J = 8.1 Hz, 2H, 2xCH), 7.76 (d, J = 8.1 Hz, 2H, 2xCH); 13C-NMR (CDCl3) δ: 14.0 (CH3), 34.2 (CH3), 45.8 (CH2), 128.2 (2xCH), 129.9 (2xCH), 131.6 (C), 138.6 (C), 142.5 (C), 148.3 (C). The C-nitro was not observed in this experiment; Anal. Calcd for C12H12N3O2Cl: C, 54.25; H, 4.55; N, 15.82. Found: C, 54.31; H, 4.61; N, 15.97.
General Procedure for the Reaction of Chloride 1 and Aromatic Carbonyl Derivatives 2a-m Using TDAE
A solution of 4-[4-(chloromethyl)phenyl]-1,2-dimethyl-5-nitro-1H-imidazole (1, 0.15 g, 0.56 mmol, 1 equiv.) in anhydrous DMF (6 mL) and the corresponding carbonyl derivative 2a-m (1.68 mmol, 3 equiv.) were placed under nitrogen at −20 °C in a two-necked flask equipped with a silica-gel drying tube and a nitrogen inlet. The solution was stirred and kept at this temperature for 30 min and then the TDAE (0.11 g, 0.56 mmol, 1 equiv.) was added dropwise via a syringe. The solution was vigorously stirred at −20 °C for 1 h and then warmed up to room temperature for 24 h [heating for 24 h at 80 °C in the case of p-nitroacetophenone (2m)]. After this time TLC analysis (CH2Cl2/EtOAc (7/3) as eluent) clearly showed that 1 was totally consumed. The orange-red turbid solution was filtered and rinsed with toluene. The organic layer was washed with H2O (3 × 40 mL) and dried over MgSO4. Evaporation of the solvent left an orange viscous liquid as crude product. Purification by silica gel chromatography [CH2Cl2/EtOAc (7:3)] gave the corresponding arylethanol or α-hydroxyester derivatives.
2-[4-(1,2-Dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]-1-(4-nitrophenyl)ethanol (3a): Beige solid; mp 200 °C (isopropyl alcohol); 1H-NMR (CDCl3) δ: 2.60 (s, 3H, CH3), 3.02–3.10 (m, 2H, CH2), 3.95 (s, 3H, CH3), 5.04 (dd, J = 5.3 Hz et J = 7.9 Hz, 1H, CH), 7.26 (d, J = 8.0 Hz, 2H, 2xCH), 7.52 (d, J = 8.7 Hz, 2H, 2xCH), 7.73 (d, J = 8.0 Hz, 2H, 2xCH), 8.20 (d, J = 8.7 Hz, 2H, 2xCH); 13C-NMR (CDCl3) δ: 13.9 (CH3), 34.1 (CH3), 45.1 (CH2), 72.7 (CH), 123.3 (2xCH), 127.3 (2xCH), 128.9 (2xCH), 129.3 (2xCH), 129.9 (C), 139.7 (C), 142.3 (C), 146.6 (C), 149.2 (C), 153.7 (C). The C-nitro was not observed in this experiment; Anal. Calcd for C19H18N4O5: C, 59.68; H, 4.74; N, 14.65. Found: C, 59.68; H, 4.92; N, 14.41.
2-[4-(1,2-Dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]-1-(3-nitrophenyl)ethanol (3b): Yellow solid; mp 225 °C (ethyl alcohol); 1H-NMR (DMSO-d6) δ: 2.45 (s, 3H, CH3), 2.94–2.99 (m, 2H, CH2), 3.81 (s, 3H, CH3), 4.96–5.04 (m, 1H, CH), 5.67–5.69 (m, 1H, OH), 7.27 (d, J = 8.2 Hz, 2H, 2xCH), 7.58 (d, J = 8.2 Hz, 2H, 2xCH), 7.64 (s, 1H, CH), 7.79 (d, J = 7.7 Hz, 1H, CH), 8.09 (d, J = 8.2 Hz, 1H, CH), 8.22 (s, 1H, CH); 13C-NMR (DMSO-d6) δ: 13.9 (CH3), 34.1 (CH3), 45.2 (CH2), 72.5 (CH), 120.7 (CH), 121.9 (CH), 128.9 (2xCH), 129.3 (2xCH), 129.6 (CH), 130.1 (C), 132.9 (CH), 134.6 (C), 139.8 (C), 142.4 (C), 147.8 (C), 148.2 (C), 149.2 (C); Anal. Calcd for C19H18N4O5: C, 59.68; H, 4.74; N, 14.65. Found: C, 59.25; H, 4.78; N, 14.36.
2-[4-(1,2-Dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]-1-(2-nitrophenyl)ethanol (3c): Orange solid; mp 216 °C (ethyl alcohol); 1H-NMR (DMSO-d6) δ: 2.45 (s, 3H, CH3), 2.80 (dd, J = 8.1 Hz et J = 13.0 Hz, 1H, CH2), 3.04 (dd, J = 8.1 Hz and J = 13.0 Hz, 1H, CH2), 3.82 (s, 3H, CH3), 5.25 (m, 1H, CH), 5.66 (d, J = 4.9 Hz, 1H, OH), 7.31 (d, J = 8.1 Hz, 2H, 2xCH), 7.53 (t, J = 8.1 Hz, 1H, CH), 7.63 (d, J = 8.1 Hz, 2H, 2xCH), 7.75 (t, J = 8.1 Hz, 1H, CH), 7.86 (d, J = 8.1 Hz, 1H, CH), 7.94 (d, J = 8.1 Hz, 1H, CH); 13C-NMR (DMSO-d6) δ: 14.0 (CH3), 34.1 (CH3), 44.7 (CH2), 69.2 (CH), 124.0 (CH), 128.4 (CH), 128.5 (CH), 129.1 (4xCH), 130.2 (C), 133.6 (CH), 134.7 (C), 140.2 (C), 140.8 (C), 142.5 (C), 147.5 (C), 149.3 (C); Anal. Calcd for C19H18N4O5: C, 59.68; H, 4.74; N, 14.65. Found: C, 58.83; H, 4.82; N, 14.01.
1-(4-Chlorophenyl)-2-[4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]ethanol (3d): Pink solid; mp 199 °C (isopropyl alcohol); 1H-NMR (DMSO-d6): 2.45 (s, 3H, CH3), 2.90 (d, J = 6.6 Hz, 2H, CH2), 3.81 (s, 3H, CH3), 4.77–4.85 (m, 1H, CH), 5.44 (d, J = 4.8 Hz, 1H, OH), 7.23 (d, J = 8.1 Hz, 2H, 2xCH), 7.35 (bs, 4H, 4xCH), 7.57 (d, J = 8.1 Hz, 2H, 2xCH); 13C-NMR (DMSO-d6) δ: 13.9 (CH3), 34.1 (CH3), 45.4 (CH2), 72.9 (CH), 128.0 (4xCH), 128.9 (2xCH), 129.2 (2xCH), 130.0 (C), 131.3 (C), 134.6 (C), 140.2 (C), 142.5 (C), 144.8 (C), 149.3 (C); Anal. Calcd for C19H18ClN3O3: C, 61.38; H, 4.88; N, 11.30. Found: C, 60.85; H, 4.94; N, 11.03.
1-(4-Bromophenyl)-2-[4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]ethanol (3e): White solid; mp 211 °C (isopropyl alcohol); 1H-NMR (DMSO-d6) δ: 2.45 (s, 3H, CH3), 2.90 (d, J = 6.5 Hz, 2H, CH2), 3.81 (s, 3H, CH3), 4.80 (q, J = 5.3 Hz, 1H, CH), 5.42 (d, J = 4.8 Hz, 1H, OH), 7.23 (d, J = 8.2 Hz, 2H, 2xCH), 7.29 (d, J = 8.4 Hz, 2H, 2xCH), 7.49 (d, J = 8.4 Hz, 2H, 2xCH), 7.57 (d, J = 8.2 Hz, 2H, 2xCH); 13C-NMR (DMSO-d6) δ: 13.9 (CH3), 34.1 (CH3), 45.3 (CH2), 72.9 (CH), 119.8 (C), 128.4 (2xCH), 128.9 (2xCH), 129.2 (2xCH), 130.0 (C), 130.9 (2xCH), 134.6 (C), 140.2 (C), 142.5 (C), 145.2 (C), 149.3 (C); Anal. Calcd for C19H18BrN3O3: C, 54.82; H, 4.36; N, 10.09. Found: C, 54.78; H, 4.42; N, 9.97.
1-(2-Bromophenyl)-2-[4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]ethanol (3f): Yellow solid; mp 228 °C (isopropyl alcohol); 1H-NMR (DMSO-d6) δ: 2.45 (s, 3H, CH3), 2.59 (dd, J = 9.0 Hz et J = 13.7 Hz, 1H, CH2), 2.98 (dd, J = 9.0 Hz and J = 13.7 Hz, 1H, CH2), 3.82 (s, 3H, CH3), 5.00–5.09 (m, 1H, CH), 5.56 (d, J = 4.9 Hz, 1H, OH), 7.20 (t, J = 7.7 Hz, 1H, CH), 7.32 (d, J = 8.0 Hz, 2H, 2xCH), 7.41 (t, J = 7.7 Hz, 1H, CH), 7.56 (s, 1H, CH), 7.62 (d, J = 8.0 Hz, 3H, 3xCH); 13C-NMR (DMSO-d6) δ: 13.9 (CH3), 34.1 (CH3), 43.9 (CH2), 72.6 (CH), 121.3 (C), 127.9 (CH), 128.0 (CH), 129.0 (5xCH), 130.1 (C), 132.3 (CH), 134.7 (C), 140.4 (C), 142.5 (C), 144.7 (C), 149.3 (C); Anal. Calcd for C19H18BrN3O3: C, 54.82; H, 4.36; N, 10.09. Found: C, 54.70; H, 4.44; N, 9.95.
4-{2-[4-(1,2-Dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]-1-hydroxyethyl}benzonitrile (3g): Yellow solid; mp 208 °C (isopropyl alcohol); 1H-NMR (DMSO-d6) δ: 2.45 (s, 3H, CH3), 2.91-2.92 (m, 2H, CH2), 3.81 (s, 3H, CH3), 4.87–4.96 (m, 1H, CH), 5.60 (d, J = 4.9 Hz, 1H, OH), 7.24 (d, J = 8.1 Hz, 2H, 2xCH), 7.56 (t, J = 8.1 Hz, 4H, 4xCH), 7.77 (d, J = 8.1 Hz, 2H, 2xCH); 13C-NMR (DMSO-d6) δ: 13.9 (CH3), 34.1 (CH3), 45.1 (CH2), 73.0 (CH), 109.6 (C), 119.2 (C), 127.1 (2xCH), 128.9 (2xCH), 129.2 (2xCH), 130.1 (C), 132.1 (2xCH), 134.6 (C), 139.8 (C), 142.5 (C), 149.3 (C), 151.6 (C); Anal. Calcd for C20H18N4O3: C, 66.29; H, 5.01; N, 15.46. Found: C, 66.17; H, 5.07; N, 15.22.
1-(4,5-Dimethoxy-2-nitrophenyl)-2-[4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]ethanol (3h): Black solid; mp 234 °C (acetonitrile); 1H-NMR (DMSO-d6) δ: 2.46 (s, 3H, CH3), 2.81 (dd, J = 7.9 Hz et J = 13.4 Hz, 1H, CH2), 3.05 (dd, J = 2.1 Hz and J = 13.4 Hz, 1H, CH2), 3.83 (s, 3H, CH3), 3.84 (s, 3H, CH3), 3.86 (s, 3H, CH3), 5.37–5.45 (m, 1H, CH), 5.61 (d, J = 4.9 Hz, 1H, OH), 7.29–7.34 (m, 3H, 3xCH), 7.59–7.65 (m, 3H, 3xCH); 13C-NMR (DMSO-d6) δ: 14.0 (CH3), 34.1 (CH3), 44.5 (CH2), 56.2 (2xCH3), 69.1 (CH), 107.5 (CH), 109.9 (CH), 129.0 (2xCH), 129.2 (2xCH), 130.2 (C), 134.7 (C), 136.8 (C), 139.1 (C), 140.3 (C), 142.6 (C), 147.4 (C), 149.3 (C), 153.3 (C); Anal. Calcd for C21H22N4O7: C, 57.01; H, 5.01; N, 12.66. Found: C, 56.81; H, 4.95; N, 12.50.
2-[4-(1,2-Dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]-1-[4-(trifluoromethyl)phenyl]ethanol (3i): Yellow solid; mp 195 °C (isopropyl alcohol); 1H-NMR (CDCl3) δ: 2.51 (s, 3H, CH3), 3.01–3.06 (m, 2H, CH2), 3.91 (s, 3H, CH3), 4.96 (dd, J = 5.5 Hz and J = 7.8 Hz, 1H, CH), 7.24 (d, J = 7.8 Hz, 2H, 2xCH), 7.46 (d, J = 8.2 Hz, 2H, 2xCH), 7.60 (d, J = 8.2 Hz, 2H, 2xCH), 7.70 (d, J = 8.2 Hz, 2H, 2xCH); 13C-NMR (CDCl3) δ: 13.9 (CH3), 34.1 (CH3), 45.3 (CH2), 73.0 (CH), 124.6 (q, J = 272 Hz, C), 124.9 (q, J = 3.5 Hz, CH), 125.0 (CH), 126.9 (2xCH), 127.6 (q, J = 31.5 Hz, C), 129.0 (2xCH), 129.2 (2xCH), 130.0 (C), 134.7 (C), 140.1 (C), 142.5 (C), 149.3 (C), 150.6 (C); Anal. Calcd for C20H18F3N3O3: C, 59.26; H, 4.48; N, 10.37. Found: C, 59.26; H, 4.81; N, 10.30.
2-[4-(1,2-Dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]-1-p-tolylethanol (3j): Yellow solid; mp 155 °C (isopropyl alcohol); 1H-NMR (CDCl3) δ: 2.16 (bs, 1H, OH), 2.34 (s, 3H, CH3), 2.50 (s, 3H, CH3), 3.05 (d, J = 6.7 Hz, 2H, CH2), 3.89 (s, 3H, CH3), 4.88 (t, J = 6.7 Hz, 1H, CH), 7.14 (d, J = 8.0 Hz, 2H, 2xCH), 7.25 (d, J = 8.0 Hz, 4H, 4xCH), 7.69 (d, J = 8.0 Hz, 2H, 2xCH); 13C-NMR (CDCl3) δ: 14.1 (CH3), 21.1 (CH3), 34.1 (CH3), 45.9 (CH2), 75.0 (CH), 125.8 (2xCH), 129.1 (2xCH), 129.2 (2xCH), 129.6 (2xCH), 130.0 (C), 134.7 (C), 137.2 (C), 139.7 (C), 140.8 (C), 143.5 (C), 148.3 (C); Anal. Calcd for C20H21N3O3: C, 68.36; H, 6.02; N, 11.96. Found: C, 68.36; H, 6.16; N, 11.90.
Ethyl 3-[4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]-2-hydroxypropanoate (3k): Yellow solid; mp 99 °C (isopropyl alcohol); 1H-NMR (CDCl3) δ: 1.28 (t, J = 7.1 Hz, 3H, CH3), 2.55 (s, 3H, CH3), 3.02 (dd, J = 6.7 Hz and J = 13.9 Hz, 1H, CH2), 3.17 (dd, J = 4.6 Hz and J = 13.9 Hz, 1H, CH2), 3.91 (s, 3H, CH3), 4.22 (q, J = 7.1 Hz, 2H, CH2), 4.46 (dd, J = 4.6 Hz and J = 6.7 Hz, 1H, CH), 7.31 (d, J = 7.9 Hz, 2H, 2xCH), 7.72 (d, J = 8.2 Hz, 2H, 2xCH); 13C-NMR (CDCl3) δ: 14.2 (CH3), 34.5 (CH3), 40.4 (CH2), 61.9 (CH2), 70.9 (CH3), 77.2 (CH), 126.8 (C), 129.6 (2xCH), 129.8 (2xCH), 134.1 (C), 139.4 (C), 139.8 (C), 147.7 (C), 173.9 (C); Anal. Calcd for C16H19N3O5: C, 57.65; H, 5.75; N, 12.61. Found: C, 57.74; H, 5.87; N, 12.65.
2-[4-(1,2-Dimethyl-5-nitro-1H-imidazol-4-yl)benzyl]-2-hydroxyacenaphthylen-1(2H)-one (3l): Yellow solid; mp 211 °C (isopropyl alcohol); 1H-NMR (DMSO-d6) δ: 2.41 (s, 3H, CH3), 3.17 (d, J = 13.2 Hz, 1H, CH2), 3.41 (d, J = 13.2 Hz, 1H, CH2), 3.77 (s, 3H, CH3), 6.99 (d, J = 7.5 Hz, 2H, 2xCH), 7.12 (bs, 1H, OH), 7.33–7.40 (m, 3H, 3xCH), 7.63–7.77 (m, 2H, 2xCH), 7.84 (d, J = 8.4 Hz, 1H, CH), 7.94 (d, J = 7.0 Hz, 1H, CH), 8.19 (d, J = 8.1 Hz, 1H, CH); 13C-NMR (DMSO-d6) δ: 13.7 (CH3), 34.2 (CH3), 42.9 (CH2), 79.8 (C), 121.3 (2xCH), 125.1 (CH), 128.5 (2xCH), 128.7 (2xCH), 129.9 (CH), 130.0 (2xCH), 130.2 (C), 131.0 (C), 132.0 (C), 134.6 (C), 137.0 (C), 140.4 (C), 140.8 (C), 141.7 (C), 149.1 (C), 205.3 (C); Anal. Calcd for C24H19N3O4: C, 69.72; H, 4.63; N, 10.16. Found: C, 69.41; H, 4.73; N, 10.13.
1-[4-(1,2-Dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]-2-(4-nitrophenyl)propan-2-ol (3m): Orange solid; mp 179 °C (acetonitrile); 1H-NMR (CDCl3) δ: 1.60 (s, 3H, CH3), 2.51 (s, 3H, CH3), 3.12 (dd, J = 13.2 Hz and J = 18.3 Hz, 2H, CH2), 3.90 (s, 3H, CH3), 7.06 (d, J = 8.3 Hz, 2H, 2xCH), 7.57 (d, J = 9.0 Hz, 2H, 2xCH), 7,63 (d, J = 8.3 Hz, 2H, 2xCH), 8.16 (d, J = 9.0 Hz, 2H, 2xCH); 13C-NMR (CDCl3) δ: 14.0 (CH3), 29.4 (CH3), 34.1 (CH3), 50.0 (CH2), 74.4 (C), 123.3 (2xCH), 126.1 (2xCH), 129.4 (2xCH), 130.2 (2xCH), 130.4 (C), 134.7 (C), 137.2 (C), 142.9 (C), 146.7 (C), 148.3 (C), 154.8 (C); Anal. Calcd for C20H20N4O5: C, 60.60; H, 5.09; N, 14.13. Found: C, 60.60; H, 5.15; N, 13.97.

4. Conclusions

We have reported the synthesis of substituted 2-[4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]-1-arylethanols, ethyl 3-[4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)phenyl]-2-hydroxypropanoate and 2-[4-(1,2-dimethyl-5-nitro-1H-imidazol-4-yl)benzyl]-2-hydroxy-acenaphthylen-1(2H)-one from the reaction of 4-[4-(chloromethyl)phenyl]-1,2-dimethyl-5-nitro-1H-imidazole with various aromatic carbonyl and α-carbonyl ester derivatives using TDAE methodology. We have shown a new application of TDAE methodology in a heterocyclic series. The pharmacological evaluation, against metronidazole-resistant lines of Blastocystis sp., of all synthesized compounds is under active investigation.

Acknowledgments

This work was supported by the Centre National de la Recherche Scientifique. We express our thanks to V. Remusat for recording the 1H- and 13C-NMR spectra.

Conflict of Interest

The authors declare no conflict of interest.

References

  1. Jorgensen, M.A.; Manos, J.; Mendz, G.L.; Hazell, S.L. The mode of action of metronidazole in Helicobacter pylori: Futile cycling or reduction? J. Antimicrob. Chemother. 1998, 41, 67–75. [Google Scholar]
  2. Upcroft, J.A.; Campbell, R.W.; Benakli, K.; Upcroft, P.; Vanelle, P. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamœba spp. Antimicrob. Agents Chemother. 1999, 43, 73–76. [Google Scholar]
  3. Upcroft, J.A.; Dunn, L.A.; Wright, J.M.; Benakli, K.; Upcroft, P.; Vanelle, P. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis. Antimicrob. Agents Chemother. 2006, 50, 344–347. [Google Scholar] [CrossRef]
  4. Leitsch, D.; Kolarich, D.; Wilson, I.B.H.; Altmann, F.; Duchêne, M. Nitroimidazole action in Entamœba histolytica: A central role for thioredoxin reductase. PLoS Biol. 2007, 5, 1820–1834. [Google Scholar]
  5. Crozet, M.D.; Botta, C.; Gasquet, M.; Curti, C.; Remusat, V.; Hutter, S.; Chapelle, O.; Azas, N.; de Méo, M.; Vanelle, P. Lowering of 5-nitroimidazole’s mutagenicity: Towards optimal antiparasitic pharmacophore. Eur. J. Med. Chem. 2009, 44, 653–659. [Google Scholar] [CrossRef]
  6. Kim, P.; Zhang, L.; Manjunatha, U.H.; Singh, R.; Patel, S.; Jiricek, J.; Keller, T.H.; Boshoff, H.I.; Barry, C.E., 3rd; Dowd, C.S. Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles. J. Med. Chem. 2009, 52, 1317–1328. [Google Scholar] [CrossRef]
  7. Çelik, A.; Ares Ateş, N. The frequency of sister chromatid exchanges in cultured human peripheral blood lymphocyte treated with metronidazole in vitro. Drug Chem. Toxicol. 2006, 29, 85–94. [Google Scholar] [CrossRef]
  8. Walsh, J.S.; Wang, R.; Bagan, E.; Wang, C.C.; Wislocki, P.; Miwa, G.T. Structural alterations that differentially affect the mutagenic and antitrichomonal activities of 5-nitroimidazoles. J. Med. Chem. 1987, 30, 150–156. [Google Scholar]
  9. Cudmore, S.L.; Delgaty, K.L.; Hayward-McClelland, S.F.; Petrin, D.P.; Garber, G.E. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin. Microbiol. Rev. 2004, 17, 783–793. [Google Scholar] [CrossRef]
  10. Schwebke, J.R.; Burgess, D. Trichomoniasis. Clin. Microbiol. Rev. 2004, 17, 794–803. [Google Scholar] [CrossRef]
  11. Crowell, A.L.; Sanders-Lewis, K.A.; Evan Secor, W. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob. Agents Chemother. 2003, 47, 1407–1409. [Google Scholar] [CrossRef]
  12. Gellis, A.; Vanelle, P.; Kaafarani, M.; Benakli, K.; Crozet, M.P. Synthesis and SRN1 reactions of nitrothiazoles. Tetrahedron 1997, 53, 5471–5484. [Google Scholar] [CrossRef]
  13. Crozet, M.P.; Gellis, A.; Pasquier, C.; Vanelle, P.; Aune, J.-P. Electron transfer reactivity in 5-nitrouracil series. Tetrahedron Lett. 1995, 36, 525–528. [Google Scholar] [CrossRef]
  14. Roubaud, C.; Vanelle, P.; Maldonado, J.; Crozet, M.P. Synthesis and SRN1 reactions of 3-nitroimidazo[1,2-a]pyrimidines. Tetrahedron 1995, 51, 9643–9656. [Google Scholar] [CrossRef]
  15. Zink, L.; Crozet, M.D.; Remusat, V.; Terme, T.; Vanelle, P. Strong thermal effect upon competition between SN2 and SRN1 reactions of nitronate anions in 4- and 5-nitroimidazole series. (unpublished results)..
  16. Mahesh, M.; Murphy, J.A.; LeStrat, F.; Wessel, H.P. Reduction of arenediazonium salts by tetrakis(dimethylamino)ethylene (TDAE): Efficient formation of products derived from aryl radicals. Beilstein J. Org. Chem. 2009, 5. [Google Scholar] [CrossRef]
  17. Burkholder, C.; Dolbier, W.R., Jr.; Médebielle, M. Tetrakis(dimethylamino)ethylene as a useful reductant of some bromodifluoromethyl heterocycles. Application to the synthesis of new gem-difluorinated heteroarylated compounds. J. Org. Chem. 1998, 63, 5385–5394. [Google Scholar] [CrossRef]
  18. Médebielle, M.; Kato, K.; Dolbier, W.R., Jr. Difluoromethylation reactions of ethyl pyruvate with TDAE – A mild approach to the synthesis of ethyl 3,3-difluoro-2-hydroxy-2-methyl-4-oxobutyrates. Synlett 2002, 1541–1543. [Google Scholar]
  19. Giuglio-Tonolo, G.; Terme, T.; Médebielle, M.; Vanelle, P. Original reaction of p-nitrobenzyl chloride with aldehydes using tetrakis(dimethylamino)ethylene (TDAE). Tetrahedron Lett. 2003, 44, 6433–6435. [Google Scholar]
  20. Amiri-Attou, O.; Terme, T.; Vanelle, P. Functionalization of 6-nitrobenzo[1,3]dioxole with carbonyl compounds via TDAE methodology. Molecules 2005, 10, 545–551. [Google Scholar] [CrossRef]
  21. Montana, M.; Terme, T.; Vanelle, P. Original synthesis of oxiranes via TDAE methodology: Reaction of 2,2-dibromomethylquinoxaline with aromatic aldehydes. Tetrahedron Lett. 2005, 46, 8373–8376. [Google Scholar] [CrossRef]
  22. Khoumeri, O.; Montana, M.; Terme, T.; Vanelle, P. First TDAE approach in quinonic series: Synthesis of new 2-substituted 1,4-dimethoxy-9,10-anthraquinones. Tetrahedron 2008, 64, 11237–11242. [Google Scholar] [CrossRef]
  23. Giuglio-Tonolo, G.; Terme, T.; Médebielle, M.; Vanelle, P. Nitrobenzylation of α-carbonyl ester derivatives using TDAE approach. Tetrahedron Lett. 2004, 45, 5121–5124. [Google Scholar] [CrossRef]
  24. Montana, M.; Crozet, M.D.; Castera-Ducros, C.; Terme, T.; Vanelle, P. Rapid synthesis of new azaheterocyclic hydroxy-malonate derivatives using TDAE approach. Heterocycles 2008, 75, 925–932. [Google Scholar] [CrossRef]
  25. Juspin, T.; Laget, M.; Terme, T.; Azas, N.; Vanelle, P. TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents. Eur. J. Med. Chem. 2010, 45, 840–845. [Google Scholar]
  26. Amiri-Attou, O.; Terme, T.; Vanelle, P. Original and rapid access to new alkaloid analogues of neocryptolepine: Synthesis of substituted 6-methyl-6H-indolo[2,3-b]quinolines via TDAE strategy. Synlett 2005, 3047–3050. [Google Scholar]
  27. Juspin, T.; Terme, P.; Vanelle, P. TDAE strategy using α-diketones: Rapid access to 2,3-diphenylquinoline and acenaphtho[1,2-b]quinoline derivatives. Synlett 2009, 1485–1489. [Google Scholar]
  28. Montana, M.; Terme, T.; Vanelle, P. TDAE-initiated synthesis of oxiranes in heterocyclic series: Reaction of 2-(dibromomethyl)quinoxaline with α-dicarbonyl derivatives. Lett. Org. Chem. 2010, 7, 453–456. [Google Scholar] [CrossRef]
  29. Crozet, M.D.; Zink, L.; Remusat, V.; Curti, C.; Vanelle, P. Efficient microwave-assisted palladium-catalyzed Suzuki-Miyaura cross-coupling reactions in 5-nitroimidazole series. Synthesis 2009, 3150–3156. [Google Scholar]
  • Sample Availability: Samples of the compounds 3a-m are available from the authors.

Share and Cite

MDPI and ACS Style

Juspin, T.; Zink, L.; Crozet, M.D.; Terme, T.; Vanelle, P. High Functionalization of 5-Nitro-1H-imidazole Derivatives: The TDAE Approach. Molecules 2011, 16, 6883-6893. https://doi.org/10.3390/molecules16086883

AMA Style

Juspin T, Zink L, Crozet MD, Terme T, Vanelle P. High Functionalization of 5-Nitro-1H-imidazole Derivatives: The TDAE Approach. Molecules. 2011; 16(8):6883-6893. https://doi.org/10.3390/molecules16086883

Chicago/Turabian Style

Juspin, Thierry, Laura Zink, Maxime D. Crozet, Thierry Terme, and Patrice Vanelle. 2011. "High Functionalization of 5-Nitro-1H-imidazole Derivatives: The TDAE Approach" Molecules 16, no. 8: 6883-6893. https://doi.org/10.3390/molecules16086883

Article Metrics

Back to TopTop